Ribocure Clinic marks milestone with first patient enrolled in a deep phenotyping clinical study
With the ambition to become the leading clinical oligonucleotide research company in Sweden, Ribocure Pharmaceuticals AB established Ribocure Clinic, with a vision to drive excellence in proof of principle/concept clinical trials with an in-house high volume and high quality Ph2 clinical trial unit. Now the first patient has been enrolled in a deep phenotyping study […]